Moreover, the review emphasises the need for additional research, including head-to-head comparisons, to comprehend the precise mechanisms of action of metformin and SGLT2 inhibitors and optimise their application in personalised medicine for autoimmune conditions. This evidence concerns the gene SLC5A2 and Autoimmunity.